The critical disclaimer that governs all products sold on retatrutide-buy.ca/. Research and laboratory use only. Not for human consumption. Not medical advice. Not Health Canada approved for therapeutic use.
Last updated: August 21, 2026. Please read this disclaimer carefully. It applies to every product sold on retatrutide-buy.ca/.
As of August 2026:
The phrase “research use only” (RUO) is a well-established regulatory category under Canada’s Food and Drugs Act, Section 30, and analogous laws in most jurisdictions worldwide. It means the product:
Nothing on retatrutide-buy.ca/ — including but not limited to product descriptions, dosing guides, side-effect discussions, review pages, and blog content — constitutes medical advice. We are not physicians, pharmacists, or licensed healthcare providers. Our content is educational and reflects information from published clinical trial data and our own product testing.
Before making any decision about your health, weight, medication use, or metabolic condition, consult with a licensed healthcare provider in your Canadian province. In British Columbia and most provinces, you can access a family physician through walk-in clinics, virtual care services (Maple, Livecare, TELUS Health MyCare), or provincial health lines (811 in most provinces).
Health Canada considers the human use of peptides not approved for therapeutic indications to be off-label use at best, and potentially in violation of the Food and Drugs Act at worst. Individuals who choose to use research chemicals for personal purposes do so entirely at their own risk and assume all legal responsibility for their actions.
Our sale of these products is legal because we sell them for research use, clearly disclosed as such, without therapeutic claims. What individual buyers subsequently do with the products they purchase is their own responsibility, not ours.
Human use of research-grade peptides carries risks that are neither adequately characterized nor covered by any regulatory framework:
Our products are not to be used in, on, or around children, pregnant or breastfeeding persons, or any individual with a known or suspected medical condition. Retatrutide and tirzepatide have both been associated with adverse effects on pregnancy and fetal development in animal studies and are contraindicated in pregnancy.
We make no claims that our products will cause weight loss, improve blood glucose, treat any disease, or produce any specific outcome in humans. Any references on retatrutide-buy.ca/ to clinical trial results (SURMOUNT-1, TRIUMPH-4, SURPASS-2, etc.) are provided for educational context about the molecule, not as claims that our products will produce similar results in any individual.
Purchasers are responsible for proper storage (2-8°C for unopened product, 2-8°C for reconstituted product), handling (aseptic technique for reconstitution, safe handling of needles and sharps), and disposal (Canadian sharps disposal protocols — typically your local pharmacy or health authority provides free sharps disposal).
By placing an order, you acknowledge that:
Canadian regulatory status of retatrutide and tirzepatide may change as clinical trials progress and Health Canada makes approval decisions. This Disclaimer will be updated to reflect regulatory changes. Product availability may be adjusted or discontinued in response to regulatory changes.
Retatrutide Buy Canada
Regulatory Officer
Suite 802, 550 Burrard Street, Vancouver, BC V6C 2B5, Canada
Email: contact@vantyxagency.com
Email: contact@vantyxagency.com
For medical concerns or adverse events, please contact your Canadian healthcare provider or Health Canada’s Canada Vigilance Program at 1-866-234-2345.
All our retatrutide, tirzepatide and combo bundles — with real Canadian pricing, cold-chain shipping and 60-day guarantee — live on one page.
Email our team for regulatory questions. For medical concerns, consult a Canadian licensed physician.
Optimized by Seraphinite Accelerator